|
|||||
| Home > Research Programs > Molecular Gerontology > References |
|||||
![]() |
|||||
Molecular Gerontology |
|||||
1. |
Nakajima, M., and Shirasawa, T. (2004).
Presenilin-1-deficient
neurons are nitric oxide-dependently killed by hydrogen
peroxide in vitro.
Neuroscience 125, 563-568. |
||||
2. |
Shin, R. M., Masuda, M., Miura, M., Sano, H.,
Shirasawa, T., Song,
W. J., Kobayashi, K., and Aosaki, T. (2003). Dopamine D4
receptor-induced
postsynaptic inhibition of GABAergic currents in mouse globus
pallidus
neurons. J Neurosci 23, 11662-11672. |
||||
3. |
Shirasawa, T. (2003). [Longevity and genes].
Nippon Ronen Igakkai
Zasshi 40, 596-598 |
||||
4. |
Izumizaki, M., Tamaki, M., Suzuki, Y., Iwase, M.,
Shirasawa, T.,
Kimura, H., and Homma, I. (2003). The affinity of hemoglobin for
oxygen
affects ventilatory responses in mutant mice with Presbyterian
hemoglobinopathy. Am J Physiol Regul Integr Comp Physiol 285,
R747-753. |
||||
5. |
Nakajima, M., Yuasa, S., Ueno, M., Takakura, N.,
Koseki, H., andShirasawa, T. (2003). Abnormal blood vessel
development in mice lackingpresenilin-1. Mech Dev 120, 657-667. |
||||
6. |
Murakami, K., Irie, K., Morimoto, A., Ohigashi,
H., Shindo, M.,Nagao, M., Shimizu, T., and Shirasawa, T. (2003).
Neurotoxicity andphysicochemical properties of Abeta mutant
peptides from cerebral amyloidangiopathy: implication for the
pathogenesis of cerebral amyloid angiopathy and Alzheimer's
disease. J Biol Chem 278, 46179-46187. |
||||
7. |
Hidenori Morio, Yoko Honda, Hidenao Yoyoda,
Mitsunari Nakajima,Hisashi Kurosawa, and Takuji Shirasawa (2002)
EXT gene family member rib-2is essential for embryonic
development and heparan sulfate biosynthesis in Caenorhabditis
elegans. Biochem Biophys Res Commun, 301, 317-323 |
||||
8. |
Takamune Takahashi, Keiko Takahashi, Patricia St.
John, Paul A..Fleming, Takuya Tomemori, Toshio Watanabe, Dale R.
Abrahamson, ChristopherJ. Drake, Takuji Shirasawa, and Thomas O.
Daniel (2002) A Mutant ReceptorTyrosine Phosphatase CD148 Causes
Defects in Vascular Development. Mol.Cell. Biol. 23, 1817-1831 |
||||
9. |
Youngah Shin, Hyun Soon Cho, Hiroyuki Fukumoto,
Takahiko Shimizu,Takuji Shirasawa, Steven M. Greenberg, and G.
William Rebeck (2002) Abspecies, including IsoAsp 23 Ab, in
Iowa-type familial cerebral amyloidangiopathy. Acta
Neuropathologica 105, 252-258 |
||||
10. |
Shirasawa, T., Izumizaki, M., Suzuki, Y. I.,
Ishihara, A., Shimizu,T., Tamaki, M., Huang, F., Koizumi, K. I.,
Iwase, M., Sakai, H., Tsuchida,E., Ueshima, K., Inoue, H.,
Koseki, H., Senda, T., Kuriyama, T., and Homma,I. (2002). Oxygen
affinity of hemoglobin regulates O2 consumption,metabolism, and
physical activity. J Biol Chem 278, 5035-5043. |
||||
11. |
Shimizu, T., Fukuda, H., Murayama, S., Izumiyama,
N., and Shirasawa,T. (2002). Isoaspartate formation at position
23 of amyloid beta peptideenhanced fibril formation and
deposited onto senile plaques and vascularamyloids in
Alzheimer's disease. J Neurosci Res 70, 451-461. |
||||
12. |
Yuasa, S., Nakajima, M., Aizawa, H., Sahara, N.,
Koizumi, K., Sakai,T., Usami, M., Kobayashi, S., Kuroyanagi, H.,
Mori, H., Koseki, H., andShirasawa, T. (2002). Impaired cell
cycle control of neuronal precursorcells in the neocortical
primordium of presenilin-1-deficient mice. JNeurosci Res 70,
501-513. |
||||
13. |
Ishigami, A., Fujita, T., Handa, S., Shirasawa,
T., Koseki, H.,Kitamura, T., Enomoto, N., Sato, N., Shimosawa,
T., and Maruyama, N. (2002).Senescence Marker Protein-30
Knockout Mouse Liver Is Highly Susceptible to Tumor Necrosis
Factor-alpha- and Fas-Mediated Apoptosis. Am J Pathol 161,
1273-1281. |
||||
14. |
Morimoto, A., Irie, K., Murakami, K., Ohigashi,
H., Shindo, M.,Nagao, M., Shimizu, T., and Shirasawa, T. (2002).
Aggregation andneurotoxicity of mutant amyloid beta (Abeta)
peptides with prolinereplacement: importance of turn formation
at positions 22 and 23. BiochemBiophys Res Commun 295, 306-311. |
||||
15. |
Ikegami, T., Suzuki, Y., Shimizu, T., Isono, K.,
Koseki, H., andShirasawa, T. (2002). Model mice for
tissue-specific deletion of themanganese superoxide dismutase (MnSOD)
gene. Biochem Biophys Res Commun 296, 729. |
||||
16. |
Suzuki, Y., Shimizu, T., Sakai, H., Tamaki, M.,
Koizumi, K.,Kuriyama, T., Tsuchida, E., Koseki, H., and
Shirasawa, T. (2002). Model mice for Presbyterian
hemoglobinopathy (Asn(beta108)-->Lys) confer hemolytic anemia
with altered oxygen affinity and instability of Hb. Biochem
Biophys Res Commun 295, 869-876. |
||||
17. |
Ogawara, M., Takahashi, M., Shimizu, T., Nakajima,
M., Setoguchi, Y.,and Shirasawa, T. (2002). Adenoviral
expression of protein-L-isoaspartylmethyltransferase (PIMT)
partially attenuates the biochemical changes inPIMT-deficient
mice. J Neurosci Res 69, 353-361. |
||||
18. |
Shimizu, T., Ikegami, T., Ogawara, M., Suzuki, Y.,
Takahashi, M.,Morio, H., and Shirasawa, T. (2002). Transgenic
expression of theprotein-L-isoaspartyl methyltransferase (PIMT)
gene in the brain rescuesmice from the fatal epilepsy of PIMT
deficiency. J Neurosci Res 69, 341-352 |
||||
19. |
Murakami, K., Irie, K., Morimoto, A., Ohigashi,
H., Shindo, M.,Nagao, M., Shimizu, T., and Shirasawa, T. (2002).
Synthesis, aggregation,neurotoxicity, and secondary structure of
various Abeta1-42 mutants offamilial Alzheimer's disease at
positions 21-23. Biochem Biophys Res Commun |
||||
20. |
Morimoto, K., Shimizu, T., Furukawa, K., Morio,
H., Kurosawa, H., andShirasawa, T. (2002). Transgenic expression
of the EXT2 gene in developingchondrocytes enhances the
synthesis of heparan sulfate and bone formation in mice. Biochem
Biophys Res Commun 292, 999-1009. |
||||
21. |
Smith, C. D., Carson, M., Friedman, A. M.,
Skinner, M. M., Delucas,L., Chantalat, L., Weise, L., Shirasawa,
T., and Chattopadhyay, D. (2002).Crystal structure of human L-isoaspartyl-O-methyl-transferase
withS-adenosyl homocysteine at 1.6-A resolution and modeling of
anisoaspartyl-containing peptide at the active site. Protein Sci
11, 625-635. |
||||
|
|
|||||
Copyright(C)2004 Tokyo Metropolitan Institute of Gerontology. All rights reserved. |
|||||